You are here

The Progress Report Progress never stops. Stay informed with the latest news on breast cancer research, treatment, and prevention.


drug resistance x

New Novel Target

A BCRF-supported study has connected a protein involved in embryonic development with drug resistance, offering a novel new avenue for targeted treatment.

Understanding how metastatic breast cancers initially respond to, and then become resistant to, treatment is critical to developing more effective treatments to improve length and quality of life in women and men living with metastatic breast cancer.  Drs.

On Pi Day, the Breast Cancer Research Foundation (BCRF) is excited to announce a new partnership that links computational scientists with biologists.

Scientists do not fully understand why tumor cells become resistant to therapy, but current research supports the possibility that it involves treatment-induced molecular or genetic changes that reprogram the cell, allowing it to survive in the presence of drugs.

This year’s Annual BCRF Symposium focused on "Progress in Killing Drug Resistant Cancer Cells" and featured panelists Dr. Joan Brugge of Harvard Medical School, Dr.

The 37th annual San Antonio Breast Cancer Symposium (SABCS) took place on December 9-13. The five-day program is attended by academic and private researchers, health professionals and advocates from around the world.